GO:0045252 oxoglutarate dehydrogenase complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045252 (oxoglutarate dehydrogenase complex, OGDHC) is a mitochondrial multi-enzyme machine that converts 2-oxoglutarate to succinyl-CoA, linking the TCA cycle to amino acid and redox metabolism [1, 5].
• The complex is built from three core enzymes: E1 (OGDH), E2 (DLST) and E3 (DLD), plus accessory proteins such as MRPS36 that stabilize the eukaryotic assembly [5, 6].
• OGDHC is a major source of reactive oxygen species and a control point for glutamate-mediated neuronal death, making it central to neurodegeneration research [1, 4].
• In Drosophila, OGDHC subunits are required for myofibril growth and Z-disc assembly, revealing non-metabolic roles in muscle development.
• OGDHL, a paralog of OGDH, can act non-canonically to induce DNA damage and suppress hepatocellular carcinoma progression.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to dissect OGDHC subunit-specific functions in disease and development [2, 3, 7].
Description
The oxoglutarate dehydrogenase complex (OGDHC; GO:0045252) is a mitochondrial multi-enzyme assembly that catalyzes the oxidative decarboxylation of 2-oxoglutarate (alpha-ketoglutarate) to succinyl-CoA, a rate-limiting step of the tricarboxylic acid (TCA) cycle [1, 5]. Because this reaction couples carbon flux to NADH production and reactive oxygen species (ROS) generation, OGDHC sits at the intersection of energy metabolism, redox balance and biosynthetic pathways [1, 8]. Researchers study OGDHC to understand how mitochondrial dysfunction contributes to neurodegeneration, cancer and inflammatory disease [1, 2, 4, 7]. The complex is composed of multiple copies of three enzymes, E1 (oxoglutarate dehydrogenase, OGDH), E2 (dihydrolipoamide S-succinyltransferase, DLST) and E3 (dihydrolipoamide dehydrogenase, DLD), with additional proteins such as MRPS36 providing structural links in eukaryotes [5, 6]. Recent structural and genetic studies have refined the subunit stoichiometry and revealed tissue-specific paralogs, including OGDHL, that can perform non-canonical functions [5, 6, 7]. Understanding OGDHC therefore requires integrating biochemistry, structural biology and CRISPR-based functional genomics [3, 5, 7].
oxoglutarate dehydrogenase complex At A Glance
| GO ID | GO:0045252 |
|---|---|
| GO term | oxoglutarate dehydrogenase complex |
| Ontology | cellular_component |
| Synonym | alpha-ketoglutarate dehydrogenase complex; dihydrolipoamide S-succinyltransferase complex; KGDHC |
| Major function | Oxidative decarboxylation of 2-oxoglutarate to succinyl-CoA, with NADH production and ROS generation [1, 5] |
| Core subunits | E1 (OGDH), E2 (DLST), E3 (DLD); accessory proteins such as MRPS36 [5, 6] |
| Subcellular location | Mitochondrial matrix, associated with the inner membrane [5, 8] |
| Cofactors | Thiamine pyrophosphate (E1), lipoic acid (E2), FAD and NAD+ (E3) [1, 8] |
| Related paralog | OGDHL, a tissue-specific paralog with non-canonical roles |
What Is GO:0045252?
GO:0045252 describes a multi-enzyme complex that catalyzes the oxidative decarboxylation of alpha-ketoglutarate (2-oxoglutarate) to form succinyl-CoA. The complex comprises multiple copies of three enzymes referred to as E1, E2 and E3: oxoglutarate dehydrogenase (lipoamide) (E1), dihydrolipoamide S-succinyltransferase (E2) and dihydrolipoamide dehydrogenase (E3). Additional proteins may also be present. In practice, this means OGDHC is a mitochondrial machine that removes a carboxyl group from 2-oxoglutarate, attaches the remaining succinyl unit to coenzyme A, and transfers electrons to NAD+ via its E3 component [1, 5, 8].
Why Is oxoglutarate dehydrogenase complex Important in Cell Biology?
OGDHC is important because it controls flux through the TCA cycle and determines the balance between energy production, ROS signaling and biosynthetic precursor supply [1, 8]. Its activity is required for normal myofibril growth and Z-disc assembly in Drosophila, showing that OGDHC supports tissue morphogenesis beyond metabolism. In neurons, OGDHC activity modulates glutamate-mediated death, linking mitochondrial metabolism to excitotoxicity. In the immune system, succinate produced downstream of OGDHC can drive FOXP3 degradation and gut inflammation, connecting the complex to inflammatory disease. In cancer, OGDHL can suppress hepatocellular carcinoma by inducing DNA damage through a non-canonical function. These diverse roles make OGDHC a high-value target for mechanistic and translational research [1, 2, 3, 4, 7].
• Rate-limiting step of the TCA cycle: OGDHC converts 2-oxoglutarate to succinyl-CoA, feeding NADH and succinate pools [1, 5].
• Neurodegeneration: OGDHC dysfunction is implicated in Alzheimer's disease and glutamate-mediated neuronal death [1, 4].
• Inflammation: succinate derived from OGDHC activity promotes FOXP3 degradation and gut inflammation.
• Muscle development: OGDHC subunits are required for myofibril growth and Z-disc assembly in Drosophila.
• Cancer: OGDHL inhibits hepatocellular carcinoma progression via DNA damage induction.
• Redox biology: OGDHC is a major mitochondrial source of reactive oxygen species [1, 8].
• Structural biology: recent cryo-EM and crosslinking studies reveal the architecture of the mammalian complex [5, 6].
• Metabolic regulation: OGDHC activity is controlled by substrate availability, NADH/NAD+ ratio and product inhibition.
• Therapeutic target: modulating OGDHC may influence neurodegeneration, inflammation and cancer [1, 2, 7].
• Model organism genetics: Drosophila and mouse models link OGDHC to development and disease [3, 4].
Structure and Composition of oxoglutarate dehydrogenase complex
E1 subunit (OGDH): the 2-oxoglutarate decarboxylase
In simple terms: E1 is the part that grabs 2-oxoglutarate and removes a carbon dioxide molecule.
E1, encoded by OGDH, is a thiamine pyrophosphate (TPP)-dependent enzyme that catalyzes the decarboxylation of 2-oxoglutarate [1, 5]. Structural studies of the mammalian complex show that E1 forms the core of the assembly and interacts with E2 to channel the reaction intermediate. In Drosophila, loss of OGDH affects myofibril growth and Z-disc assembly, indicating that E1 function is required for muscle development. OGDH is also a key source of ROS in neurons, and its activity modulates glutamate-mediated death.
E2 subunit (DLST): the lipoamide succinyltransferase
In simple terms: E2 is the scaffold that holds the complex together and transfers the succinyl group to coenzyme A.
E2, encoded by DLST, forms the structural core of OGDHC and catalyzes the transfer of the succinyl group from lipoamide to coenzyme A, producing succinyl-CoA [5, 6]. The E2 core is composed of multiple copies that assemble into a cubic or dodecahedral shape, and it anchors E1 and E3. In eukaryotes, MRPS36 provides a structural link that stabilizes the interaction between E2 and E3, refining the architecture of the complex. DLST is therefore essential for the catalytic cycle and for the overall integrity of OGDHC [5, 6].
E3 subunit (DLD): the dihydrolipoamide dehydrogenase
In simple terms: E3 is the part that recycles the lipoamide arm and produces NADH.
E3, encoded by DLD, is a FAD-dependent enzyme that reoxidizes dihydrolipoamide and transfers electrons to NAD+, generating NADH [1, 5]. E3 is shared with other mitochondrial multi-enzyme complexes, including pyruvate dehydrogenase and branched-chain ketoacid dehydrogenase. In the OGDHC context, E3 is recruited to the E2 core and its activity is essential for continuous turnover of the complex [5, 6]. Mutations in DLD can affect multiple complexes, but its role in OGDHC is critical for TCA cycle flux.
Accessory proteins and assembly factors
In simple terms: Extra proteins help build and stabilize the complex.
Beyond E1, E2 and E3, additional proteins may be present in OGDHC [5, 6]. MRPS36, a mitochondrial ribosomal protein, was identified as a structural link in the eukaryotic 2-oxoglutarate dehydrogenase complex, bridging E2 and E3. The mammalian complex architecture has been resolved by cryo-electron microscopy, revealing a 12-meric E2 core with E1 and E3 arranged around it. These accessory factors are important for assembly, stability and regulation of OGDHC [5, 6].
Subcellular localization and mitochondrial context
In simple terms: The complex lives inside mitochondria, attached to the inner membrane.
OGDHC is located in the mitochondrial matrix and is associated with the inner mitochondrial membrane [5, 8]. This localization places it close to the electron transport chain, allowing efficient NADH oxidation and ROS production [1, 8]. The complex is also spatially organized with other TCA cycle enzymes to facilitate substrate channeling. In neurons, mitochondrial localization is critical for glutamate-mediated death, as OGDHC activity influences ROS and energy balance.
Key Genes Involved in GO:0045252 oxoglutarate dehydrogenase complex
The following genes encode the core subunits, accessory proteins and related enzymes of the oxoglutarate dehydrogenase complex, all of which are studied using CRISPR-based models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| OGDH | E1 subunit; decarboxylates 2-oxoglutarate | Neuronal death, ROS production, TCA cycle flux [1, 5] |
| DLST | E2 subunit; transfers succinyl group to CoA | Core scaffold, assembly, structural studies [5, 6] |
| DLD | E3 subunit; reoxidizes lipoamide, produces NADH | Shared with other complexes, redox balance [5, 8] |
| MRPS36 | Accessory protein linking E2 and E3 | Eukaryotic complex stability, structural link |
| OGDHL | Paralog of OGDH; non-canonical functions | Hepatocellular carcinoma suppression, DNA damage |
| DHTKD1 | Related 2-oxoadipate dehydrogenase | Metabolic disorders, not core OGDHC but related |
| PDHA1 | Pyruvate dehydrogenase E1, shares E3 | Cross-talk with OGDHC via DLD |
| PDHB | Pyruvate dehydrogenase E2, shares E3 | Cross-talk with OGDHC via DLD |
| BCKDHA | Branched-chain ketoacid dehydrogenase E1 | Shares E3, metabolic integration |
| BCKDHB | Branched-chain ketoacid dehydrogenase E2 | Shares E3, metabolic integration |
| DLAT | Dihydrolipoamide acetyltransferase | Related multi-enzyme complex |
| GOT2 | Aspartate aminotransferase, links glutamate to 2-OG | Glutamate metabolism, neuronal death |
| GLUD1 | Glutamate dehydrogenase, produces 2-OG | Substrate supply for OGDHC |
| SLC25A11 | Mitochondrial 2-oxoglutarate carrier | Substrate transport, TCA cycle |
| FOXP3 | Transcription factor degraded by succinate | Gut inflammation, immune regulation |
| SDHA | Succinate dehydrogenase, downstream of OGDHC | TCA cycle, succinate accumulation |
| SUCLG1 | Succinyl-CoA ligase, uses succinyl-CoA | TCA cycle, metabolic flux |
| SUCLA2 | Succinyl-CoA ligase, uses succinyl-CoA | TCA cycle, metabolic flux |
How Is oxoglutarate dehydrogenase complex Regulated?
OGDHC is regulated at multiple levels. Its activity is controlled by substrate availability (2-oxoglutarate), product inhibition (succinyl-CoA and NADH), and the NADH/NAD+ ratio, which reflects the mitochondrial redox state. The complex is also regulated by post-translational modifications and by the availability of its cofactors, including thiamine pyrophosphate, lipoic acid, FAD and NAD+ [1, 8]. In neurons, OGDHC activity is linked to glutamate metabolism and ROS production, and its dysfunction can trigger cell death. In Drosophila, OGDHC subunits are required for myofibril growth, suggesting developmental regulation. In cancer, OGDHL expression is often downregulated, and its non-canonical function induces DNA damage, indicating that OGDHC-related genes can be regulated at the transcriptional level. The complex is also influenced by mitochondrial protein import and assembly factors such as MRPS36.
oxoglutarate dehydrogenase complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| OGDH | Alzheimer's disease, neuronal death | CRISPR knockout in neurons, mouse models [1, 4] |
| DLST | Metabolic and neurodegenerative disorders | Knockout cell lines, structural studies [5, 6] |
| DLD | Redox imbalance, metabolic disease | Point-mutation knock-in, patient-derived cells |
| OGDHL | Hepatocellular carcinoma | Overexpression and knockout in liver cancer cells |
| FOXP3 | Gut inflammation | Knockout T cells, succinate treatment |
Neurodegeneration and Alzheimer's disease
OGDHC dysfunction has been implicated in Alzheimer's disease, where reduced activity of the complex contributes to mitochondrial impairment and neuronal death. The complex controls glutamate-mediated neuronal death by modulating ROS production and energy metabolism, making it a potential therapeutic target. Literature reviews and bioinformatics workflows have highlighted OGDHC as a key mitochondrial enzyme in Alzheimer's disease pathology.
Inflammation and gut immunity
Succinate, produced downstream of OGDHC, drives gut inflammation by promoting FOXP3 degradation through a molecular switch. This links OGDHC activity to immune cell function and inflammatory bowel disease. The complex therefore represents a metabolic checkpoint in immune regulation.
Cancer and hepatocellular carcinoma
OGDHL, a paralog of OGDH, inhibits the progression of hepatocellular carcinoma by inducing DNA damage through a non-canonical function. This suggests that OGDHC-related genes can act as tumor suppressors independent of their metabolic role. Targeting OGDHL or OGDHC may offer new strategies for cancer therapy.
Muscle development and myopathies
In Drosophila, the oxoglutarate dehydrogenase complex is involved in myofibril growth and Z-disc assembly, indicating that OGDHC dysfunction could contribute to muscle developmental defects. This non-metabolic role highlights the importance of OGDHC in tissue morphogenesis and potential myopathies.
From oxoglutarate dehydrogenase complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does OGDH loss affect neuronal survival? | CRISPR knockout of OGDH in neuronal cell lines or primary neurons |
| How does DLST mutation affect complex assembly? | Point-mutation knock-in of DLST in HEK293 cells [5, 6] |
| Can OGDHL overexpression suppress tumor growth? | Overexpression of OGDHL in hepatocellular carcinoma cells |
| What is the role of MRPS36 in OGDHC stability? | Knockout of MRPS36 followed by proteomics |
| Does OGDHC control myofibril growth? | Drosophila knockout of OGDH or DLST |
| How does succinate drive FOXP3 degradation? | Knockout of OGDHC subunits in T cells, succinate supplementation |
How to Study the oxoglutarate dehydrogenase complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotypes | Identify essential OGDHC subunits [1, 3] |
| Point-mutation knock-in | Specific residue function | Dissect catalytic residues in DLST or DLD [5, 6] |
| Overexpression | Gain-of-function effects | Study OGDHL tumor suppression |
| Proteomics | Protein interactions and complex composition | Identify MRPS36 and assembly factors |
| Cryo-EM | 3D structure of the complex | Determine architecture of mammalian OGDHC |
| Metabolomics | Metabolite levels and flux | Measure TCA cycle activity [1, 8] |
| Live-cell imaging | ROS and mitochondrial function | Assess neuronal death |
| Drosophila genetics | Developmental phenotypes | Study myofibril growth |
CRISPR knockout screens
CRISPR knockout screens can identify genes required for OGDHC function and its downstream effects. For example, knocking out OGDH, DLST or DLD in cell lines followed by metabolomics and viability assays reveals their essential roles [1, 5]. In Drosophila, knockout of OGDHC subunits causes myofibril defects, demonstrating the power of genetic screens in vivo.
Proteomics and structural biology
Affinity purification coupled to mass spectrometry has identified MRPS36 as a structural link in the eukaryotic OGDHC. Cryo-electron microscopy has resolved the molecular architecture of the mammalian complex, revealing subunit stoichiometry and assembly. These methods are essential for understanding how mutations affect complex integrity [5, 6].
Metabolomics and flux analysis
Metabolomics can measure 2-oxoglutarate, succinyl-CoA, succinate and NADH levels to assess OGDHC activity [1, 8]. Stable isotope tracing can quantify flux through the TCA cycle and identify compensatory pathways. In inflammation models, succinate levels are linked to FOXP3 degradation.
Imaging and functional assays
Live-cell imaging of mitochondrial ROS and membrane potential can report OGDHC activity in neurons. Immunofluorescence can visualize Z-disc assembly in Drosophila muscle. These assays complement genetic and biochemical approaches [1, 3].
How CRISPR Can Be Used to Study GO:0045252 oxoglutarate dehydrogenase complex
Knockout
CRISPR knockout of OGDH, DLST or DLD in cell lines or animal models can reveal their essential roles in mitochondrial metabolism and development [1, 3, 5]. For example, OGDH knockout in neurons increases susceptibility to glutamate-mediated death, while DLST knockout disrupts complex assembly [1, 5]. In Drosophila, knockout of OGDHC subunits impairs myofibril growth.
Point Mutation
Point-mutation knock-in can model specific catalytic residues or patient variants in OGDHC subunits. For instance, mutating the lipoamide attachment site in DLST or the FAD-binding site in DLD can dissect their catalytic mechanisms [5, 6]. Such models are valuable for understanding how single amino acid changes affect complex activity and stability [5, 8].
Knock-in
Knock-in of tagged versions of OGDH, DLST or DLD (e.g., GFP or HA) allows visualization and affinity purification of the complex [5, 6]. This approach can be used to study assembly, localization and interaction partners in live cells [5, 6]. Knock-in of disease-associated mutations can also model human disorders [4, 8].
Overexpression
Overexpression of OGDHL in hepatocellular carcinoma cells suppresses tumor growth by inducing DNA damage, demonstrating the potential of gain-of-function studies. Overexpression of wild-type or mutant OGDHC subunits can also reveal dominant-negative effects or rescue phenotypes [7, 8].
How EDITGENE Supports oxoglutarate dehydrogenase complex Research
Researchers studying oxoglutarate dehydrogenase complex-related genes often need to determine whether a candidate gene is causally involved in mitochondrial metabolism, neuronal survival or tumor suppression. EDITGENE provides custom CRISPR cell models and screening services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for oxoglutarate dehydrogenase complex research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| BCKDK Knockout HEK293 Cell Line | EDJ-KQ1127 | Human | 10295 | Details Get a Quote |
| KGD4 Knockout HEK293 Cell Line | EDJ-KQ10857 | Human | 92259 | Details Get a Quote |
| OGDHL Knockout HEK293 Cell Line | EDJ-KQ14554 | Human | 55753 | Details Get a Quote |
| BCKDK Knockout HCT 116 Cell Line | EDJ-KQ18979 | Human | 10295 | Details Get a Quote |
| OGDHL Knockout HCT 116 Cell Line | EDJ-KQ44847 | Human | 55753 | Details Get a Quote |
| BCKDK Knockout A-549 Cell Line | EDJ-KQ20324 | Human | 10295 | Details Get a Quote |
| BCKDK Knockout HeLa Cell Line | EDJ-KQ20326 | Human | 10295 | Details Get a Quote |
| KGD4 Knockout HCT 116 Cell Line | EDJ-KQ37235 | Human | 92259 | Details Get a Quote |
| KGD4 Knockout A-549 Cell Line | EDJ-KQ38520 | Human | 92259 | Details Get a Quote |
| KGD4 Knockout HeLa Cell Line | EDJ-KQ38521 | Human | 92259 | Details Get a Quote |
| Kat2a Knockout HBZY-1 Cell Line | EDJ-KZ301 | Rat | 2648 | Details Get a Quote |
| OGDHL Knockout HeLa Cell Line | EDJ-KQ56627 | Human | 55753 | Details Get a Quote |
| OGDHL Knockout A-549 Cell Line | EDJ-KQ65127 | Human | 55753 | Details Get a Quote |
Frequently Asked Questions About oxoglutarate dehydrogenase complex
What is the oxoglutarate dehydrogenase complex?
The oxoglutarate dehydrogenase complex (OGDHC; GO:0045252) is a mitochondrial multi-enzyme complex that converts 2-oxoglutarate to succinyl-CoA, comprising E1 (OGDH), E2 (DLST) and E3 (DLD) [1, 5].
What genes are involved in the oxoglutarate dehydrogenase complex?
Core genes include OGDH (E1), DLST (E2) and DLD (E3), with accessory proteins such as MRPS36 and the paralog OGDHL [5, 6, 7].
What is the function of GO:0045252?
GO:0045252 catalyzes the oxidative decarboxylation of alpha-ketoglutarate to succinyl-CoA, producing NADH and ROS as part of the TCA cycle [1, 8].
How is the oxoglutarate dehydrogenase complex regulated?
It is regulated by substrate availability, NADH/NAD+ ratio, product inhibition and cofactor availability, as well as by assembly factors like MRPS36 [6, 8].
What diseases are linked to OGDHC dysfunction?
OGDHC dysfunction is linked to Alzheimer's disease, glutamate-mediated neuronal death, gut inflammation and hepatocellular carcinoma [1, 2, 4, 7].
What is the role of OGDHL in cancer?
OGDHL inhibits hepatocellular carcinoma progression by inducing DNA damage through a non-canonical function.
How does OGDHC affect neurons?
OGDHC controls glutamate-mediated neuronal death by modulating ROS production and energy metabolism.
What is the structure of the mammalian OGDHC?
The mammalian complex has a 12-meric E2 core with E1 and E3 arranged around it, and MRPS36 provides a structural link [5, 6].
Can CRISPR be used to study OGDHC?
Yes, CRISPR knockout, point-mutation knock-in, knock-in tagging and overexpression models are widely used to dissect OGDHC subunit functions [1, 3, 5, 7].
What model organisms are used for OGDHC research?
Drosophila is used to study myofibril growth, while mammalian cell lines and mouse models are used for neurodegeneration and cancer research [1, 3, 4, 7].
Conclusion
The oxoglutarate dehydrogenase complex (GO:0045252) is a central mitochondrial machine that links TCA cycle flux to redox balance, neuronal survival, immune regulation and cancer suppression [1, 2, 4, 7]. Its multi-subunit architecture, including E1, E2, E3 and accessory proteins like MRPS36, provides numerous entry points for mechanistic studies [5, 6]. CRISPR-based models are indispensable for dissecting the specific roles of each subunit in health and disease [1, 3, 5, 7]. EDITGENE offers comprehensive services to accelerate this research.
References
- 1. Weidinger A et al.. 2023. Oxoglutarate dehydrogenase complex controls glutamate-mediated neuronal death.. Redox Biol 62:102669 PMID: 36933393
- 2. Wang H et al.. 2025. Succinate drives gut inflammation by promoting FOXP3 degradation through a molecular switch.. Nat Immunol 26(6):866-880 PMID: 40457062
- 3. González Morales N et al.. 2023. The oxoglutarate dehydrogenase complex is involved in myofibril growth and Z-disc assembly in Drosophila.. J Cell Sci 136(13) PMID: 37272588
- 4. Sayehmiri F et al.. 2026. The role of 2-Oxoglutarate dehydrogenase complex mitochondrial enzyme in alzheimer's disease: a literature review and bioinformatics workflow.. Metab Brain Dis 41(1) PMID: 41945181
- 5. Zhang Y et al.. 2024. Molecular architecture of the mammalian 2-oxoglutarate dehydrogenase complex.. Nat Commun 15(1):8407 PMID: 39333186
- 6. Hevler JF et al.. 2023. MRPS36 provides a structural link in the eukaryotic 2-oxoglutarate dehydrogenase complex.. Open Biol 13(3):220363 PMID: 36854377
- 7. Jiang X et al.. 2023. Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical function.. Cell Death Differ 30(8):1931-1942 PMID: 37419985
- 8. Tylicki A et al.. 2011. [2-Oxoglutarate dehydrogenase complex and its multipoint control].. Postepy Biochem 57(3):304-13 PMID: 22235656
